Key result
In a healthy population in Ahvaz, Iran, the prevalence of JCV DNA and BKV DNA in urine samples was 6.09% and 12.8%, respectively.
Cross-Sectional (n=164)
No
A notable proportion of healthy individuals asymptomatically excrete JCV and BKV in urine, suggesting a need for screening prior to immunosuppressive therapy.
Answers are grounded in this paper and cite their sources.
May inform baseline polyomavirus risk in healthy adults; leaves open whether pre-immunosuppression screening improves outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dehcheshmeh et al. (2020) conducted a cross-sectional in Healthy individuals (n=164). Polyomavirus JC and BK was evaluated on Prevalence of JCV DNA and BKV DNA in urine samples. In a healthy population in Ahvaz, Iran, the prevalence of JCV DNA and BKV DNA in urine samples was 6.09% and 12.8%, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: